its been recommended numerous times AMBS hire an IR firm to publicize and promo the company, especially with a product release such as LymPro on the horizon. I know other investors who say without a marketing firm employed, the public exposure is greatly reduced. Instead monies are spent elsewhere.

Maybe biotechexpert is right:

Quote:

---

"But then again, if Lympro is only targeting RUO, we might not see much of a pr blitz."

---

Also I see the 25 Milestones stickie removed when it was once there. Obviously if it was good enough to have been posted once, and IMHO, there was no good enough reason to have it removed, other than for personal reasons...interesting practices on this thread...as usual...